US · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Encision, Inc. ECIA
15 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$6.6M
▼ 0.5% vs FY2023
EPS · FY24
$-0.02
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
-12.7%
Net margin · FY24
-3.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 6.6M
Revenue, FY2024 · full 15-year series below
Revenue
Net income
The company lost 3 cents on every revenue dollar this year.
Per share
USD -0.02
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
-12.7%
Return on equity, FY2024
ROE
Operating margin-2.6%
Net margin-3.4%
Return on assets-5.9%
Each USD of equity lost 13 cents this year.
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−3.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−5.1%
−3.1%
−3.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2024
Change, 5 years+2.6%
Change, 10 years+11.3%
The share count grew 3% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.7M
total assets, end of FY2024
Total assetsUSD 3.7M
EquityUSD 1.7M
CashUSD 257,433.00
Gross debtUSD 5,000.00
Net debtUSD -252,433.00
Current ratio1.66×
The company holds more cash than debt.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
Net income $B
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
EPS, diluted $
−0.02
−0.06
−0.03
−0.01
0.05
−0.02
−0.02
0.03
−0.07
−0.08
−0.13
−0.20
−0.08
−0.08
0.00
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−12.7
−32.0
−12.4
−2.4
23.5
−8.7
−10.4
16.8
−34.2
−30.7
−35.2
−39.7
−13.5
−12.5
0.1
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
59 of 59
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed